Skip to main content
. Author manuscript; available in PMC: 2012 Mar 21.
Published in final edited form as: J Cardiovasc Pharmacol. 2011 Jan;57(1):122–130. doi: 10.1097/FJC.0b013e3182010a96

Figure 6.

Figure 6

Immunostaining for thromboxane synthase (TS) and receptor (TR). Co-staining for TS and SMA (A) demonstrated localization in the vascular smooth muscle, and no obvious differences between groups; 1) control, 2) NAP, and 3) CBX. Immunostaining for TR and SMA (B) also showed localization in the vascular smooth muscle and no major differences in expression levels between groups; 1) control, 2) NAP, and 3) CBX.